feature,value,label,precision,recall,f1-score,support
dosage,osimertinib | 80 mg,osimertinib + 80 mg,0.5,0.143,0.222,8
dosage,gefitinib | None,gefitinib + None,0.0,0.0,0.0,3
dosage,erlotinib | 150 mg,erlotinib + 150 mg,0.0,0.0,0.0,2
dosage,gefitinib | 250 mg,gefitinib + 250 mg,0.0,0.0,0.0,4
dosage,afatinib | None,afatinib + None,0.0,0.0,0.0,1
dosage,afatinib | 80 mg,afatinib + 80 mg,0.0,0.0,0.0,2
dosage,afatinib | 40 mg,afatinib + 40 mg,0.0,0.0,0.0,1
dosage,gefitinib | 80 mg,gefitinib + 80 mg,1.0,0.5,0.667,2
dosage,erlotinib | 100 mg,erlotinib + 100 mg,0.0,0.0,0.0,1
dosage,Osimertinib | 80 mg,Osimertinib + 80 mg,0.5,0.143,0.222,8
dosage,gefinitib | 250 mg,gefinitib + 250 mg,0.0,0.0,0.0,1
dosage,cisplatino | None,cisplatino + None,0.0,0.0,0.0,1
dosage,Afatinib | 80 mg,Afatinib + 80 mg,0.0,0.0,0.0,2
dosage,ceftriaxone | None,ceftriaxone + None,0.0,0.0,0.0,1
dosage,Gefitinib | 250 mg,Gefitinib + 250 mg,0.0,0.0,0.0,4
dosage,erlotinib | AUC4,erlotinib + AUC4,0.0,0.0,0.0,1
frequency,osimertinib | 1 cp die,osimertinib + 1 cp die,0.0,0.0,0.0,1
frequency,gefitinib | None,gefitinib + None,0.0,0.0,0.0,2
frequency,osimertinib | qd,osimertinib + qd,0.0,0.0,0.0,5
frequency,erlotinib | qd,erlotinib + qd,0.0,0.0,0.0,2
frequency,gefitinib | 1 cp/die,gefitinib + 1 cp/die,0.0,0.0,0.0,1
frequency,gefitinib | qd,gefitinib + qd,0.0,0.0,0.0,3
frequency,afatinib | None,afatinib + None,0.0,0.0,0.0,1
frequency,afatinib | 1 cp die,afatinib + 1 cp die,0.0,0.0,0.0,2
frequency,osimertinib | 80 mg/die,osimertinib + 80 mg/die,1.0,1.0,1.0,1
frequency,afatinib | qd,afatinib + qd,0.0,0.0,0.0,1
frequency,gefitinib | 80 mg/die,gefitinib + 80 mg/die,1.0,1.0,1.0,1
frequency,gefitinib | 1 cp al giorno,gefitinib + 1 cp al giorno,0.0,0.0,0.0,2
frequency,erlotinib | None,erlotinib + None,1.0,1.0,1.0,1
frequency,Osimertinib | 1 compressa al giorno,Osimertinib + 1 compressa al giorno,0.0,0.0,0.0,1
frequency,gefinitib | 250 mg/die,gefinitib + 250 mg/die,0.0,0.0,0.0,1
frequency,cisplatino | None,cisplatino + None,0.0,0.0,0.0,1
frequency,Afatinib | 1 cp die,Afatinib + 1 cp die,0.0,0.0,0.0,2
frequency,ceftriaxone | None,ceftriaxone + None,0.0,0.0,0.0,1
frequency,Gefitinib | 1 cp al giorno,Gefitinib + 1 cp al giorno,0.0,0.0,0.0,2
period,osimertinib | None,osimertinib + None,0.5,0.143,0.222,8
period,gefitinib | None,gefitinib + None,0.0,0.0,0.0,9
period,erlotinib | 9 cicli,erlotinib + 9 cicli,0.0,0.0,0.0,1
period,afatinib | None,afatinib + None,0.0,0.0,0.0,4
period,erlotinib | None,erlotinib + None,1.0,0.5,0.667,2
period,Osimertinib | None,Osimertinib + None,0.5,0.143,0.222,8
period,gefinitib | None,gefinitib + None,0.0,0.0,0.0,1
period,cisplatino | None,cisplatino + None,0.0,0.0,0.0,1
period,Afatinib | None,Afatinib + None,0.0,0.0,0.0,4
period,ceftriaxone | None,ceftriaxone + None,0.0,0.0,0.0,1
period,gefitinib | 3 cycles,gefitinib + 3 cycles,0.0,0.0,0.0,1
period,Gefitinib | None,Gefitinib + None,0.0,0.0,0.0,9
mutation,osimertinib | Exon 19 del,osimertinib + Exon 19 del,0.0,0.0,0.0,3
mutation,gefitinib | Exon 19 del,gefitinib + Exon 19 del,0.0,0.0,0.0,3
mutation,osimertinib | L858R,osimertinib + L858R,0.0,0.0,0.0,3
mutation,erlotinib | exon 19 del,erlotinib + exon 19 del,0.0,0.0,0.0,1
mutation,gefitinib | L861Q,gefitinib + L861Q,0.0,0.0,0.0,1
mutation,gefitinib | altre mutazioni,gefitinib + altre mutazioni,0.0,0.0,0.0,2
mutation,afatinib | exon 19 del,afatinib + exon 19 del,0.0,0.0,0.0,1
mutation,gefitinib | L858R,gefitinib + L858R,0.0,0.0,0.0,2
mutation,afatinib | T790M,afatinib + T790M,0.0,0.0,0.0,2
mutation,osimertinib | altre mutazioni,osimertinib + altre mutazioni,0.0,0.0,0.0,1
mutation,erlotinib | L858R,erlotinib + L858R,0.0,0.0,0.0,2
mutation,Osimertinib | None,Osimertinib + None,0.0,0.0,0.0,1
mutation,gefinitib | L861Q,gefinitib + L861Q,0.0,0.0,0.0,1
mutation,cisplatino | None,cisplatino + None,0.0,0.0,0.0,1
mutation,Afatinib | L861Q,Afatinib + L861Q,0.0,0.0,0.0,1
mutation,osimertinib | G719C+E709K,osimertinib + G719C+E709K,0.0,0.0,0.0,1
mutation,ceftriaxone | None,ceftriaxone + None,0.0,0.0,0.0,1
mutation,gefitinib | T790M,gefitinib + T790M,0.0,0.0,0.0,1
mutation,Gefitinib | None,Gefitinib + None,0.0,0.0,0.0,1
mutation,erlotinib | L858R+L858R,erlotinib + L858R+L858R,0.0,0.0,0.0,1
exon,osimertinib | esone 19,osimertinib + esone 19,0.0,0.0,0.0,3
exon,gefitinib | esone 19,gefitinib + esone 19,0.0,0.0,0.0,4
exon,osimertinib | esone 21,osimertinib + esone 21,0.0,0.0,0.0,3
exon,erlotinib | esone 19,erlotinib + esone 19,0.0,0.0,0.0,1
exon,gefitinib | None,gefitinib + None,0.0,0.0,0.0,3
exon,afatinib | esone 19,afatinib + esone 19,0.0,0.0,0.0,2
exon,gefitinib | esone 21,gefitinib + esone 21,0.0,0.0,0.0,2
exon,afatinib | None,afatinib + None,0.0,0.0,0.0,1
exon,osimertinib | esone 18,osimertinib + esone 18,1.0,1.0,1.0,1
exon,erlotinib | 	esone 21,erlotinib + 	esone 21,0.0,0.0,0.0,1
exon,erlotinib | esone 21,erlotinib + esone 21,1.0,1.0,1.0,1
exon,Osimertinib | None,Osimertinib + None,0.0,0.0,0.0,1
exon,gefinitib | esone 21,gefinitib + esone 21,0.0,0.0,0.0,1
exon,cisplatino | None,cisplatino + None,0.0,0.0,0.0,1
exon,Afatinib | esone 21,Afatinib + esone 21,0.0,0.0,0.0,1
exon,ceftriaxone | None,ceftriaxone + None,0.0,0.0,0.0,1
exon,gefitinib | esone 20,gefitinib + esone 20,0.0,0.0,0.0,1
exon,Gefitinib | None,Gefitinib + None,0.0,0.0,0.0,3
modality,osimertinib | None,osimertinib + None,0.0,0.0,0.0,8
modality,gefitinib | None,gefitinib + None,0.5,0.143,0.222,8
modality,erlotinib | orale,erlotinib + orale,0.0,0.0,0.0,1
modality,gefitinib | orale,gefitinib + orale,0.0,0.0,0.0,1
modality,afatinib | None,afatinib + None,0.0,0.0,0.0,3
modality,erlotinib | None,erlotinib + None,1.0,0.5,0.667,2
modality,Osimertinib | None,Osimertinib + None,0.0,0.0,0.0,8
modality,gefinitib | orale,gefinitib + orale,0.0,0.0,0.0,1
modality,cisplatino | endovenosa,cisplatino + endovenosa,0.0,0.0,0.0,1
modality,Afatinib | orale,Afatinib + orale,0.0,0.0,0.0,1
modality,osimertinib | orale,osimertinib + orale,0.0,0.0,0.0,1
modality,ceftriaxone | endovenosa,ceftriaxone + endovenosa,0.0,0.0,0.0,1
modality,Gefitinib | None,Gefitinib + None,0.5,0.143,0.222,8
is_tki,osimertinib | True,osimertinib + True,0.5,0.143,0.222,8
is_tki,gefitinib | True,gefitinib + True,0.5,0.125,0.2,9
is_tki,erlotinib | True,erlotinib + True,1.0,0.333,0.5,3
is_tki,afatinib | True,afatinib + True,0.0,0.0,0.0,4
is_tki,Osimertinib | True,Osimertinib + True,0.5,0.143,0.222,8
is_tki,gefinitib | False,gefinitib + False,0.0,0.0,0.0,1
is_tki,cisplatino | False,cisplatino + False,0.0,0.0,0.0,1
is_tki,Afatinib | True,Afatinib + True,0.0,0.0,0.0,4
is_tki,ceftriaxone | False,ceftriaxone + False,0.0,0.0,0.0,1
is_tki,Gefitinib | True,Gefitinib + True,0.5,0.125,0.2,9
